1873 fundamentals
VIVA BIOTECH HOLDINGS revenue breakdown overview
VIVA BIOTECH HOLDINGS revenue for the last year amounted to 2.37 B HKD, the most of which — 1.45 B HKD — came from its highest performing source at the moment, Contract Development Manufacture Organisation and Commercialisation, the year earlier bringing 1.73 B HKD. The greatest contribution to the revenue figure was made by United States — last year it brought VIVA BIOTECH HOLDINGS 898.13 M HKD, and the year before that — 1.06 B HKD.
By source
2016
2017
2018
2019
2020
2021
2022
2023
0.00
700.00 M
1.40 B
2.10 B
2.80 B
Contract Development Manufacture Organisation and Commercialisation
Drug Discovery
Non-investees - Full-time-Equivalent
Non-investees - Fee-for-Service
Investees - Service-for-Equity
Investees - Full-time-Equivalent
Investees - Fee-for-Service
Currency: HKD
2016
2017
2018
2019
2020
2021
2022
2023
Contract Development Manufacture Organisation and Commercialisation
—
290.08 M
1.64 B
1.73 B
1.45 B
Drug Discovery
366.32 M
493.09 M
892.43 M
1.04 B
933.59 M
Non-investees - Full-time-Equivalent
—
—
—
—
—
Non-investees - Fee-for-Service
—
—
—
—
—
Investees - Service-for-Equity
—
—
—
—
—
Investees - Full-time-Equivalent
—
—
—
—
—
Investees - Fee-for-Service
—
—
—
—
—
By country
2016
2017
2018
2019
2020
2021
2022
2023
0.00
700.00 M
1.40 B
2.10 B
2.80 B
United States
European Union
China
Other Asian Countries
Other Countries/Regions
Africa
Currency: HKD
2016
2017
2018
2019
2020
2021
2022
2023
United States
276.21 M
446.02 M
779.20 M
1.06 B
898.13 M
European Union
2.04 M
143.25 M
711.35 M
591.29 M
651.46 M
China
84.45 M
130.63 M
454.05 M
444.66 M
357.66 M
Other Asian Countries
—
—
397.82 M
456.78 M
321.99 M
Other Countries/Regions
3.61 M
63.27 M
104.05 M
134.45 M
102.92 M
Africa
—
—
89.40 M
75.06 M
49.76 M